In addition, activation of the interleukin (IL)-6/STAT3 pathway promotes tumor survival through the upregulation of anti-apoptotic myeloid cell leukemia sequence 1 (55, 56) and cyclin A1 (57), while also stimulating downstream expression of S100 calcium-binding protein A9 (S100A9). The gene discussed is IL6; the disease is neoplasm.